Big Pharma and the Persisting Problem
We are now entering a post-antibiotic era where alternative strategies need to be investigated to help combat future pandemics and further cancer treatment. The status quo simply is not sustainable.
At Birmingham Technologies, we are pushing the boundaries of technological innovations in biochemistry and immunology that will forever alter the way we fight and cure disease. By deploying nanoscale medicine, it is now possible to rapidly create vaccines in minutes, allowing for personalized treatment that evolves to continuously combat cancer and infectious disease at every stage. This revolutionary approach creates a scalable treatment landscape, amenable to a large number of pathogens—paving the way towards terminating pandemics and curing cancer.
The vaccines can be created in mere minutes and have no antibiotic resistance, do not require refrigeration, have not elicited any side-effects, and can be created in a lab or prepared in the field.